• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS NEUROSTIMULATOR
Device Problem Insufficient Information (3190)
Patient Problems Bacterial Infection (1735); Fluid Discharge (2686); Test Result (2695)
Event Date 06/23/2015
Event Type  Injury  
Event Description
On (b)(6) 2014: patient was implanted after phase ii testing with rns neurostimulator, one depth lead ((b)(4)) and three cortical strip leads ((b)(4)).The depth lead was placed in the left hippocampus; the strip lead that was connected to the neurostimulator was placed in the left temporal region.The remaining two leads were not connected and were placed as follows: left sub-temporal and left temporal mid-lateral.On (b)(6) 2015: patient was scheduled for a left temporal resection with revision of neuropace implanted depth and strip leads.Neurosurgeon performed a craniotomy for resection and noted a copious amount of discharge under the bone flap extending to the subdural space.Neurosurgeon abandoned the resection and proceeded with explant of all neuropace implanted product.Neurosurgeon noted that further laboratory analysis would be needed to identify discharge.Pre-surgical workup for patient indicated no evidence or clinical signs of infection.On (b)(6) 2015: workup summary and patient update received from the nurse practitioner at (b)(6).Operating room lab cultures were taken at the latest surgery on (b)(6) 2015.The cultures grew out p.Acnes on the culture broth.Other plates were negative as of (b)(6) 2015.Esr=1 (esr is used as a marker for tissue inflammation).Normal is 0-20 for women.C-reactive protein was less than 5 (another type of marker for tissue inflammation.) the patient was started on ceftriaxone after surgery along with vancomycin.The vancomycin was discontinued after the results came back from the lab.Patient is being maintained on ceftriaxone 2gm x 6 weeks total.This antibiotic will be given by iv thru a pic line.
 
Manufacturer Narrative
(b)(4).No product return.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key4928923
MDR Text Key6431093
Report Number3004426659-2015-00005
Device Sequence Number1
Product Code PFN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberRNS NEUROSTIMULATOR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/23/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age27 YR
-
-